8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Nov 8, 2010)

Filed November 8, 2010For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on November 8, 2010, primarily to report on its financial results and condition for the quarter ended September 30, 2010. The company held a conference call on November 4, 2010, to discuss these results and other important information. The filing incorporates by reference the script of this conference call and the risk factors detailed in their Form 10-Q, also filed on November 4, 2010. This report serves as an important update for investors, providing insights into the company's performance and potential challenges. Investors are directed to review the conference call script and risk factors for a comprehensive understanding of DexCom's operational and financial standing during the third quarter of 2010. The disclosure emphasizes that these materials are deemed "filed" under Section 18 of the Exchange Act, meaning they are subject to the anti-fraud provisions of federal securities laws.

Key Highlights

  • 1DexCom held a conference call on November 4, 2010, to discuss its third-quarter 2010 financial results.
  • 2The 8-K filing incorporates the script of the conference call (Exhibit 99.01) by reference.
  • 3The filing also incorporates the company's risk factors as detailed in its Form 10-Q (Exhibit 99.02), filed on the same date.
  • 4Information provided in this 8-K is considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
  • 5This filing serves to update investors on the company's financial condition and operational results for the period ended September 30, 2010.
  • 6Investors are advised to read the conference call script and risk factors in conjunction for a complete understanding.

Frequently Asked Questions

The primary purpose of this 8-K filing is to provide investors with the financial results and condition of DexCom, Inc. for the quarter ended September 30, 2010, by incorporating the materials from a related conference call and the company's Form 10-Q.

The details of DexCom's third-quarter 2010 performance are primarily available through the script of the conference call (Exhibit 99.01) and the risk factors (Exhibit 99.02) included in this 8-K filing, both of which are incorporated by reference from documents filed on November 4, 2010.

Yes, the information contained in this Item 2.02 of the 8-K, including the referenced exhibits, is deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. This means it is subject to the liabilities and protections of that section, including anti-fraud provisions.

The key documents referenced and incorporated by reference are the DexCom Third Quarter 2010 Earnings Release Script (Exhibit 99.01) and the Risk Factors from DexCom's Form 10-Q filed on November 4, 2010 (Exhibit 99.02).